InspireMD, Inc. filed a Form 8-K on September 21, 2026, disclosing that it entered into amendments with certain holders of its Series J and Series K common stock purchase warrants, modifying the exercise price and termination date for a portion of those warrants.
Immunology research matters for Aclaris Therapeutics (NASDAQ:ACRS) because developing treatments for immune and inflammatory diseases is what the company does. Aclaris is a clinical-stage biotechnology firm working on therapies that modulate the immune system to treat conditions in which it malfunctions, inflammatory skin diseases …
Dick's Sporting Goods, Inc. filed a Form 8-K on September 21, 2026, providing unaudited pro forma condensed combined financial information reflecting the completed acquisition of Foot Locker, Inc. for the fiscal year ended January 31, 2026.
Deep Fission, Inc. filed a Form 8-K with the SEC on September 21, 2026, disclosing a press release announcing its collaboration with Youngquist Brothers, LLC to evaluate and test drilling and borehole-construction methods for the company's underground reactor deployment model.
Ennis, Inc. filed a Form 8-K with the SEC on September 21, 2026, disclosing a quarterly cash dividend increase and announcing financial results for the three and six months ended August 31, 2026.
Occupancy shapes American Assets Trust (NYSE:AAT) because, as a landlord, its income comes directly from rent, and rent depends on how much of its space is leased and at what rate. A real estateInvestmenttrust like American Assets Trust owns income-producing property and passes most …
Industrial demand could shape Ascent Industries (NASDAQ:ACNT) because the company now makes specialty chemicals used in a range of industrial and consumer applications, and demand for those chemistries drives its sales. Ascent has been transforming itself, sharpening its focus on specialty chemicals and moving …
Treatment adoption matters forAlphaCognition (NASDAQ:ACOG) because winning regulatory approval for a drug is only half the battle; the harder task is convincing physicians to prescribe it and payers to cover it. Alpha Cognition has moved past the approval milestone that stops most biotechs in …
Aclarion (NASDAQ:ACON) connects theNasdaqComposite to the search for a better way to diagnose chronic back pain, one of medicine's most common yet stubbornly imprecise conditions. Standard imaging, such as MRI, can show structural changes in the spine but often can't reliably identify which specific …
Commercial property credit matters for ACRES Commercial Realty (NYSE:ACR) because, rather than owning buildings and collecting rent like a typical REIT, ACRES originates and manages loans secured by commercial real estate. Its income comes from the spread between what it charges borrowers and what …